Skip to main content

Proceeding contribution from Earl Howe (Conservative) in the House of Lords on Tuesday, 15 January 2008. It occurred during Debate on bill on Human Fertilisation and Embryology Bill [HL].


Human Fertilisation and Embryology Bill [HL]

My Lords, I strongly support the noble Lord, Lord Patel, in the objectives that he is trying to achieve through these amendments. However, I need to ask the same question that I asked during the debate on Amendment No. 4. If treatments are developed of the kind referred to by the noble Lord, which we all hope may emerge from the research, would it potentially be for the HFEA to license those treatments or would it be for the MHRA? If it is the MHRA, is it for this Bill to deal with the matter? I hope that the Minister will cover that point when she replies. If we are, through this amendment, changing the remit of the HFEA, we need to know that we are doing that, and we need to decide, and appreciate, how this impacts on the role and work of other regulators.


Secondary information

Type
Proceeding contribution
Reference
697 c1248 
Session
2007-08
Chamber / Committee
House of Lords chamber
Subjects
Animals Congenital abnormalities Fertility Licensing Human embryo experiments Diseases Genetics Human Fertilisation and Embryology Authority Ethics IVF Research Stem cells Human-animal hybrid embryos
Legislation
Human Fertilisation and Embryology Bill (HL) 2007-08
Link
View this Proceeding contribution on www.publications.parliament.uk